Drug Type Small molecule drug |
Synonyms 3',5,7-trihydroxy-4'-methoxyflavone 7-rhamnoglucoside, 3',5,7-trihydroxy-4'-methoxyflavone-7-rutinoside, diosmetin 7-neohesperidoside + [5] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (04 Jun 2004), |
RegulationOrphan Drug (US) |
Molecular FormulaC28H32O15 |
InChIKeyGZSOSUNBTXMUFQ-YFAPSIMESA-N |
CAS Registry520-27-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Chronic venous insufficiency | CN | 04 Jun 2004 | |
Hemorrhoids | CN | 04 Jun 2004 |
Phase 4 | 90 | (Experimental: Rivaroxaban + Diosmin + Stockings) | snzmjuvlcr(eaugeokogu) = fczdvidqme sokqhmlmxo (tmmwgxkcyl, kuiydjndbz - ydsqkfxsue) View more | - | 27 Jan 2020 | ||
compression stockings+rivaroxaban (Control: Rivaroxaban + Stockings Only) | snzmjuvlcr(eaugeokogu) = jkhahrxrxr sokqhmlmxo (tmmwgxkcyl, ogawdujtxy - gjsdlldnbj) View more |